NURC
NOTICE OF UPDATED REGISTRATION CONFIRMATION EMAILED
05/05/2026
Back to search
Official data from USPTO
BIOPHARMCATALYST
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
BIOPHARMCATALYST
ST13
US500000090037875Class
35, 36, 42
Filing
90037875
Registration
6496435
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
42
Latest update
05/05/2026
Trademark type
Word
Nice classes
35, 36, 42
Filing date
07/06/2020
Registration date
09/28/2021
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
09/28/2021
Last transaction
05/05/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Foreign priority
Drawing code
4
Owner type
03
Owner location
Solana Beach, CA, US
Examiner
OPUTA, CHIOMA N
Current location
Historical data usage
Holders and representatives
Holders
ASSAY DEPOT INC.
ASSAY DEPOT INC.
HIROSHI MANAGEMENT LIMITED
Representatives
Pollie Gautsch, Esq. G&A LEGAL, APC
Technical classification
Nice Classes
Class 35Class 36Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 35
Compiling indexes of information relevant to financial investment decisions
Class 36
Providing stock market information; financial analysis and information services; financial analysis and information servicesproviding information to investors about the timing of the results of clinical trials for pharmaceuticals to aid investors in making financial investment decisions; providing investors with financial information relevant to financial investment decisions; informationadvisoryconsultancy and research services relating to finance and investments; providing financial analysis of pharmaceutical companies listed on the U.S. stock marketfor investment purposes; providing financial analysis of pharmaceutical companies listed on the U.S. stock marketfor research purposes; providing investment information relating to pharmaceutical development; any of the aforementioned services when provided via a website or via a newsletter
Class 42
Providing medical and scientific research information about the results of clinical trials for pharmaceuticals; analysis of technical pharmaceutical research data; provision of information and data relating to medical and veterinary research and development; providing information relating to pharmaceutical development including the results of clinical trials and pending clinical trial data of ongoing trialsfor research purposes; any of the aforementioned services when provided via a website or via a newsletter
Publications
History of USPTO decisions and trademark events.
42 publications found
COC.
CORRECTION UNDER SECTION 7 - PROCESSED
04/10/2026
ES7R
TEAS SECTION 7 REQUEST RECEIVED
03/20/2026
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
03/20/2026
PRAM
POST REGISTRATION ACTION MAILED - SEC. 7
01/06/2026
EROP
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
12/04/2025
PRAM
POST REGISTRATION ACTION MAILED - SEC. 7
12/02/2025
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
12/02/2025
ES7R
TEAS SECTION 7 REQUEST RECEIVED
09/16/2025
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
12/23/2024
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
12/23/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
12/23/2024
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
12/23/2024
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
12/23/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
09/28/2021
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
08/04/2021
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
07/29/2021
EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
07/29/2021
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
07/29/2021
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
07/29/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
07/13/2021
PUBO
PUBLISHED FOR OPPOSITION
07/13/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
06/23/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
06/09/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
06/08/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/08/2021
ALIE
ASSIGNED TO LIE
06/03/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
03/05/2021
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
12/02/2020
GNRT
NON-FINAL ACTION E-MAILED
12/02/2020
CNRT
NON-FINAL ACTION WRITTEN
12/02/2020
AMPX
PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
12/02/2020
PARI
TEAS VOLUNTARY AMENDMENT RECEIVED
11/18/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
11/12/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
11/11/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
11/11/2020
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
10/20/2020
GNRT
NON-FINAL ACTION E-MAILED
10/20/2020
CNRT
NON-FINAL ACTION WRITTEN
10/20/2020
DOCK
ASSIGNED TO EXAMINER
10/13/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
08/03/2020
NWAP
NEW APPLICATION ENTERED
07/09/2020
Continuous trademark protection
Get notified about every new filing that threatens BIOPHARMCATALYST or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.